biotech
James Sabry Departs Roche After 14 Years, Returns to Biotech Industry
James Sabry, Roche, Genentech, Biotech, Partnering, Pharmaceutical Industry, Career Moves
BioNTech Strengthens ADC Partnership with China’s MediLink, Investing $25M Upfront
BioNTech, MediLink Therapeutics, Antibody-Drug Conjugate (ADC), Solid Tumors, TMALIN ADC Platform, Biotech Collaboration, China, Germany
Revitalizing Cancer Therapy: UK Biotech Acquires Kyowa Kirin’s Former Drug for Epstein-Barr-Related Diseases
UK Biotech, Kyowa Kirin, cancer drug, Epstein-Barr virus, EBV-driven diseases, drug acquisition, therapy revival.
Cytokinetics’ Royalty Agreement Dampens Merger and Acquisition Hopes, Say Investors
Cytokinetics, Merger and Acquisition (M&A), Royalty Agreement, Investors, Biotech Industry
Biotech Company Raises $54M to Dominate Dendritic Cell-Amplifying Vaccines Market
Biotech, $54M funding, Dendritic cell-amplifying vaccines, Market cornering, Immune response, Apex regulators
Regeneron Unveils $500M Biotech-Focused Venture Capital Fund
Regeneron, Venture Capital Fund, Biotech, $500 million
#FierceMadness: The Battle for the Best Biotech Names Reaches the Sweet 16
#FierceMadness, Best Biotech Name Tournament, Sweet 16, Bracket Challenge, Fierce Biotech, Creative Branding, Biopharma Industry
“#FierceMadness 2024: Best Biotech Name Tournament Round of 32 Results”
#FierceMadness, Best Biotech Name Tournament, Round of 32 Results, Drug Names, Marketing Suitability, Mounjaro, Daybue, Beyfortus, Wainua, Fierce Biotech, Voting Results
Novo Nordisk Acquires Mid-Stage Heart Failure Biotech Cardior for Up to $1.1 Billion
Novo Nordisk, Cardior Pharmaceuticals, Heart Failure Biotech, Acquisition, $1.1 billion